NeoGenomics NEO Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $146.14M-57.8% | $159.62M-56.5% | $164.12M-54.7% | $154.72M-56.4% | $346.19M+4.3% | ||
| $167.42M+10.7% | $159.24M+5.8% | $155.3M+2.6% | $153.13M+4.5% | $151.21M+7.8% | ||
| $29.84M+0.2% | $28.57M+6.8% | $28.46M+16.4% | $34.17M+47.2% | $29.77M+46.5% | ||
| $373.68M-34.9% | $376.29M-36.9% | $382.47M-35.2% | $392.55M-32.8% | $573.93M0.0% | ||
| $83.66M-6.6% | $84.83M-9.8% | $85.47M-8.1% | $85.46M-7.3% | $89.6M+2.0% | ||
| $524M+0.2% | $524.34M+0.3% | $524.34M+0.3% | $524.14M+0.3% | $522.77M0.0% | ||
| $265.45M-16.5% | $286.53M-15.6% | $280.72M-19.3% | $288.35M-19.1% | $317.87M-12.9% | ||
| $972.85M-5.3% | $983.54M-5.6% | $992.32M-5.6% | $1B-5.4% | $1.03B-3.7% | ||
| $1.35B-15.9% | $1.36B-17.0% | $1.37B-16.2% | $1.39B-15.2% | $1.6B-2.4% | ||
| $25.9M+59.8% | $23.09M+6.9% | $22.61M+36.9% | $27.49M+60.0% | $16.21M-11.6% | ||
| $561K-51.8% | $851K+108% | $1.58M+168% | $1.08M+11.5% | $1.16M+1.7% | ||
| $84.59M-69.8% | $88.3M-70.7% | $97.87M-67.0% | $100.12M-65.5% | $279.7M+265% | ||
| $433.18M-0.1% | $434.97M+0.1% | $438.62M+0.5% | $439.79M+0.5% | $433.47M-32.3% | ||
| $517.77M-27.4% | $523.27M-28.9% | $536.49M-26.8% | $539.91M-25.8% | $713.16M-0.5% | ||
| $129K+0.8% | $129K+0.8% | $128K0.0% | $128K0.0% | $128K+0.8% | ||
| -$450.91M-28.2% | -$433.81M-33.2% | -$423.93M-36.5% | -$396.8M-35.5% | -$351.7M-28.3% | ||
| $828.76M-6.7% | $836.56M-7.3% | $838.29M-7.7% | $854.04M-6.8% | $888.27M-3.8% | ||
| $1.35B-15.9% | $1.36B-17.0% | $1.37B-16.2% | $1.39B-15.2% | $1.6B-2.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are NeoGenomics's total assets?
- NeoGenomics (NEO) holds $1.3B in total assets, down 15.9% year over year.
- How much debt does NeoGenomics have?
- NeoGenomics carries $66.3M in total debt against $828.8M of shareholders' equity, a debt-to-equity ratio of 0.08.
- How much cash does NeoGenomics have?
- NeoGenomics holds $146.1M in cash and equivalents.
- Can NeoGenomics cover its short-term obligations?
- Its current ratio is 4.42 — current assets exceed current liabilities.
- Where does NeoGenomics's balance sheet data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
